NIS 8.8 million given to incubators

Among the new technologies slated for development are new water purification systems for the municipality of Dimona, user-identification software for Internet sites and robotically controlled flexible needles for use in delicate medical procedures.

By MATTHEW KRIEGER
April 26, 2007 10:01

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The committee of technology development at the Chief Scientist's Office on Wednesday allotted NIS 8.8 million to five technology incubators that will develop new technologies in the fields of environmental protection, software and medical equipment. Among the new technologies slated for development are new water purification systems for the municipality of Dimona, user-identification software for Internet sites and robotically controlled flexible needles for use in delicate medical procedures.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS